MAGIC Clinic Ltd

Calgary, Alberta T2E 7Z4

3 studies enrolling now · 6 studies all time

What they study most

Angelman Syndrome, Fabry Disease, Fabry Disease, Cardiac Variant, Gaucher Disease Type 1, Mucopolysaccharidosis II

Studies at this site

• A Gaucher Disease Gene Therapy Trial With FLT201 — Recruiting now
• Long-term Extension of GTX-102 in Angelman Syndrome — Enrolling by invitation
• Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR) — Completed
• A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome — Completed
• Long-Term Follow-up of Subjects Who Were Treated With ST-920 — Enrolling by invitation
• Safety and Efficacy of HMI-203 in ERT-Treated Adults With MPS II — Withdrawn before enrolling